Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Benzenesulfonic acid excipient

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4ATRACURIUM BESYLATE

    02 4ATRACURIUM BESYLATE PRESERVATIVE FREE

    03 5CISATRACURIUM BESYLATE

    04 2CISATRACURIUM BESYLATE PRESERVATIVE FREE

    05 1NIMBEX

    06 1NIMBEX PRESERVATIVE FREE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CISATRACURIUM BESYLATE

    Drug : NIMBEX PRESERVATIVE FREE

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 20551

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ABBVIE
    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CISATRACURIUM BESYLATE

    Drug : NIMBEX

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 20551

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    EUGIA PHARMA

    Atracurium Besylate

    ELCC
    Not Confirmed
    arrow

    04

    EUGIA PHARMA

    Atracurium Besylate

    ELCC
    Not Confirmed
    arrow

    05

    HOSPIRA INC

    Atracurium Besylate

    ELCC
    Not Confirmed
    arrow

    06

    HOSPIRA INC

    Atracurium Besylate

    ELCC
    Not Confirmed
    arrow

    07

    ZYDUS PHARMS

    Cisatracurium Besylate

    ELCC
    Not Confirmed
    arrow

    08

    ZYDUS PHARMS

    Cisatracurium Besylate

    ELCC
    Not Confirmed
    arrow

    09

    NORVIUM BIOSCIENCE

    Atracurium Besylate

    ELCC
    Not Confirmed
    arrow
    NORVIUM BIOSCIENCE
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ATRACURIUM BESYLATE

    Drug : ATRACURIUM BESYLATE PRESERVATIVE FREE

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 206001

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    NORVIUM BIOSCIENCE

    Atracurium Besylate

    ELCC
    Not Confirmed
    arrow
    NORVIUM BIOSCIENCE
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ATRACURIUM BESYLATE

    Drug : ATRACURIUM BESYLATE

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 206096

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF